Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.56 |
| ▸ | FNTA | P49354 | 13/20 | 0.51 |
| ▸ | FNTB | P49356 | 13/20 | 0.51 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30408279 | 0.85 | FNTA (0.48) | FOLH1FNTAFNTBPGGT1B | |
| SCHEMBL31067326 | 0.81 | FNTA (0.50) | FOLH1FNTAFNTBPGGT1B | |
| SCHEMBL29525963 | 0.81 | FNTA (0.50) | FOLH1FNTAFNTBPGGT1B | |
| SCHEMBL9830354 | 0.80 | ALDH1A1 (0.56) | FNTAFNTBPGGT1B | |
| SCHEMBL9830361 | 0.80 | ALDH1A1 (0.56) | FNTAFNTBPGGT1B | |
| SCHEMBL34473997 | 0.80 | FNTA (0.58) | FNTAFNTBPGGT1B | |
| SCHEMBL30051582 | 0.80 | FNTA (0.58) | FNTAFNTBPGGT1B | |
| SCHEMBL30051176 | 0.80 | FNTA (0.68) | FNTAFNTBPGGT1B | |
| SCHEMBL31688029 | 0.79 | FNTA (0.51) | FNTAFNTBPGGT1B | |
| SCHEMBL30495535 | 0.79 | FNTA (0.51) | FOLH1FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689892-B1 | RADIOACTIVE DRUG | UNIV CHIBA NAT UNIV CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-11167050-B2 | Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2021-11-09 | — | — | US | disclosed |
| US-10960089-B2 | Radiolabeled drug | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2021-03-30 | — | — | US | disclosed |
| US-20200268913-A1 | RADIOACTIVE DRUG | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3689892-A1 | RADIOACTIVE DRUG | National University Corporation Chiba University (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20190091353-A1 | RADIOLABELED DRUG | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11167050-B2 | Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound | SLC30A6, AP1M1, SLC39A11 | FOLH1 348/4885FNTA 3251/4885FNTB 2008/4885 |
| US-20190091353-A1 | RADIOLABELED DRUG | SLC10A1, SLCO2A1, SLC30A5 | FOLH1 125/4885FNTA 3126/4885FNTB 2561/4885 |
| US-20200268913-A1 | RADIOACTIVE DRUG | TFRC, LUC7L2, MRPL19 | FOLH1 48/4885FNTA 3551/4885FNTB 1815/4885 |
| US-10960089-B2 | Radiolabeled drug | TFRC, CLINT1, SLC10A1 | FOLH1 168/4885FNTA 2157/4885FNTB 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.